GLOBOCAN 2008
CANCER FACT SHEET
  
  Incidence
  Mortality

Prostate Cancer Incidence and Mortality Worldwide in 2008
Summary

Estimated numbers (thousands)CasesDeaths
 World899258
 More developed regions644136
 Less developed regions255121
 WHO Africa region (AFRO)3424
 WHO Americas region (PAHO)33476
 WHO East Mediterranean region (EMRO)129
 WHO Europe region (EURO)37994
 WHO South-East Asia region (SEARO)2819
 WHO Western Pacific region (WPRO)10933
 IARC membership (22 countries)611128
 United States of America18628
 China3314
 India1410
 European Union (EU-27)32371
Estimated age-standardised rates (World) per 100,000
   At a glance

Prostate cancer is the second most frequently diagnosed cancer of men (899 000 new cases, 13.6% of the total) and the fifth most common cancer overall. Nearly three-quarters of the registered cases occur in developed countries (644 000 cases). Incidence rates of prostate cancer vary by more than 25-fold worldwide, the highest rates are in Australia/New Zealand (104.2 per 100,000), Western and Northern Europe, Northern America, largely because the practice of prostate specific antigen (PSA) testing and subsequent biopsy has become widespread in those regions. Incidence rates are relatively high in certain developing regions such as the Caribbean, South America and sub-Saharan Africa. The lowest age-standardised incidence rate is estimated in South-Central Asia (4.1 per 100,000).
With an estimated 258 000 deaths in 2008, prostate cancer is the sixth leading cause of death from cancer in men (6.1% of the total). Because PSA testing has a much greater effect on incidence than on mortality, there is less variation in mortality rates worldwide (10-fold) than is observed for incidence (25-fold), and the number of deaths from prostate cancer is almost the same in developed and developing regions. Mortality rates are generally high in predominantly black populations (Caribbean, 26.3 per 100,000 and sub-Saharan Africa, ASRs 18-19 per 100,000), very low in Asia (ASR 2.5 per 100,000 in Eastern Asia for example) and intermediate in Europe and Oceania.
  
GLOBOCAN 2008 (IARC) , Section of Cancer Information (19/5/2013)
IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2010 - All Rights Reserved - Email: www@iarc.fr

Estimated Prostate Cancer Incidence Worldwide in 2008

You need to upgrade your Flash Player

05.815.027.567.7174
Age-standardised incidence rates per 100,000

Roll over the map for country rates.
Click onto the map and zoom with mouse wheel.
GLOBOCAN 2008, International Agency for Research on Cancer

 Trends in incidence of prostate cancer in selected countries: age-standardised rate (W) per 100,000
NORDCAN (www.ancr.nu) France: INVS
Ireland: www.ncri.ie
The Netherlands: www.ikcnet.nl
England: www.statistics.gov.uk
Scotland: www.isdscotland.org
Wales: www.wales.nhs.uk
Australia: www.aihw.gov.au
Canada: www.statcan.gc.ca
India: Chennai cancer registry
Japan: Miyagi, Osaka and Yamagata cancer registries
Republic of Korea: www.ncc.re.kr
USA: SEER program: seer.cancer.gov
GLOBOCAN 2008 (IARC) , Section of Cancer Information (19/5/2013)
IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2010 - All Rights Reserved - Email: www@iarc.fr

Estimated Prostate Cancer Mortality Worldwide in 2008

You need to upgrade your Flash Player

03.88.012.716.862
Age-standardised mortality rates per 100,000

Roll over the map for country rates.
Click onto the map and zoom with mouse wheel.
GLOBOCAN 2008, International Agency for Research on Cancer

 Trends in mortality from prostate cancer in selected countries: age-standardised rate (W) per 100,000
WHO (www.who.int/whosis) WHO (www.who.int/whosis) WHO (www.who.int/whosis)
GLOBOCAN 2008 (IARC) , Section of Cancer Information (19/5/2013)
IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2010 - All Rights Reserved - Email: www@iarc.fr